Alon Weizer completed his undergraduate education at Duke University. He completed medical school at Baylor College of Medicine in Houston, TX and returned to Duke Univeristy where he complete a 6 year training program in general surgery and urology. He then completed a 2-year fellowship at the University of Michigan in Ann Arbor, MI in Urologic Oncology and Minimally Invasive Surgery. He completed a Masters in Clinical Research Statistical Design and Analysis at Rackham during his forst two years as faculty here at UM. His clinical and research interest is focused on prevention and early detection of bladder cancer, novel treatments for early bladder cancer, and the use of minimally invasive approaches to treat bladder, prostate, kidney, testicular, and genitourniary malignancies. In addition to his clinical and research interests, he is currently the Medical Director of the Cancer Center Ambulatory Care Unit. He lives in Ann Arbor, MI with his wife and three children.
Clinical Trials for Bladder and Prostate Cancer; Early Detection and Prevention of Bladder Cancer; Novel Treatments for early bladder cancer
Anudeep Mukkamala; Chang He; Alon Z. Weizer; Khaled S. Hafez; David C. Miller; Jeffrey S. Montgomery; J. Stuart Wolf.Long-term oncologic outcomes of minimally invasive partial nephrectomy for renal-cell carcinoma.Journal of Endourology. 2014;28(6):649-654.
Michael Hu; Bruce L. Jacobs; Jeffrey S. Montgomery; Chang He; Jun Ye; Yun Zhang; Julien Brathwaite; Todd M. Morgan; Khaled S. Hafez; Alon Z. Weizer; et al.Sharpening the focus on causes and timing of readmission after radical cystectomy for bladder cancer.Cancer. 2014;120(9):1409-1416.
Rohit Mehra; Pankaj Vats; Shanker Kalyana-Sundaram; Aaron M. Udager; Michael Roh; Ajjai Alva; Jincheng Pan; Robert J. Lonigro; Javed Siddiqui; Alon Weizer; et al.Primary urethral clear-cell adenocarcinoma: Comprehensive analysis by surgical pathology, cytopathology, and next-generation sequencing.American Journal of Pathology. 2014;184(3):584-591.